In Vitro and in Vivo Evaluation of the Anti-Inflammatory and Antithrombotic Synergy of Vitamin C and Bioflavonoids in Healthy Subjects

NCT ID: NCT07061431 Phase: NA Status: COMPLETED Enrollment: 20 Completion: 2025-05-31

Conditions

Cardio-protection

Interventions

High Dose of Vitamin C with ir without 50 mg of flavonoids

Summary

This study aimed to evaluate the antioxidant potential, and especially the anti-inflammatory and antiplatelet biological efficacy and synergy of a high dose (1 g) vitamin C - low dose (50 mg) bioflavonoid (VCF) based supplement using both in vitro approaches and an and in vivo clinical trial in human platelets from healthy subjects administered orally for 1 month the VCF supplement (VCF Group) versus the administration of a 1 g vitamin C supplement (VC Group).

Primary Outcome

Anti-platelet cardio-protective efficacy

Source

ClinicalTrials.gov